Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs MultiMedRx

boostAGErx
Graded #183

Higher grade

vs+9.199999999999996
MultiMedRx
Graded #394

Lower grade

The verdict

boostAGErx takes it — 66.8/100 to 57.6/100.

boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth brand offering compounded GLP-1 weight management (semaglutide and tirzepatide) starting around $95/mo on a 12-month upfront plan, plus peptide therapy such as…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +29
74
45
Dose & formulationboostAGErx +24
77
53
Clinical oversightMultiMedRx +5
74
79
Labs & monitoringMultiMedRx +1
52
53
FulfillmentboostAGErx +2
69
67
Contract termsMultiMedRx +24
25
49
boostAGErx · left barMultiMedRx · right bar

The numbers

MetricboostAGErxMultiMedRx
WeighScore66.8/10057.6/100
GradeCC
Scorecard rank#183#394
Semaglutide$95/mo (starting dose, compounded)Not disclosed
Tirzepatide$95/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
boostAGErx

Graded #183 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Headline $95/mo requires a 12-month upfront commitment; actual price varies by product/plan
  • Compounded medications are non-refundable once dispensed
  • Pharmacy partner not named on the site
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
MultiMedRx

Graded #394 · C

Strengths

  • Legal entity disclosed (MMRX MultiMedRx LLC) — uncommon transparency
  • Two physical addresses listed: Newport Beach, CA and Reno, NV
  • LegitScript seal present
  • Features brand-name GLP-1s (Ozempic, Wegovy, Zepbound) — rare in a mostly compounded-only field
  • Broader cardiometabolic menu (metformin, testosterone, HRT) alongside GLP-1

Where it loses points

  • No Mounjaro or Foundayo in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
  • Monthly GLP-1 pricing isn't published — gated behind the consultation
  • $100 consultation fee adds friction; many peers bundle it into the medication price
  • Per-state availability not listed; only CA and NV offices disclosed
  • Whether compounded GLP-1 is offered isn't clear — verify during intake

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard